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Summary
 
There is little known about the regulation of gene expression during TCR-mediated differen-
tiation of immature CD4
 
1
 
8
 
1
 
 (double positive) thymocytes into mature T cells. Using the DPK
CD4
 
1
 
8
 
1
 
thymocyte precursor cell line, we demonstrate that the early growth response-1 gene
(
 
Erg-1
 
), encoding a zinc finger transcription factor, is rapidly upregulated after TCR stimula-
tion. We also report that Egr-1 is expressed by a subset of normal double positive thymocytes
in the thymic cortex, as well by a majority of medullary single positive thymocytes. Expression
of Egr-1 is dramatically reduced in the thymus of major histocompatibility complex knockout
mice, but can be induced by anti-CD3 antibody stimulation of isolated thymocytes from these
animals. These and other data suggest that high level expression of Egr-1 in the thymus is a
consequence of selection. A similar pattern of expression is found for family members Egr-2
and Egr-3. Using the DPK cell line, we also demonstrate that expression of Egr-1, 2, and 3 is
dependent upon ras activation, as is the initiation of differentiation to a single positive cell. In
contrast, the calcineurin inhibitor cyclosporin A, which inhibits DPK cell differentiation as
well as positive selection, inhibits expression of Egr-2 and Egr-3, but not Egr-1. The identifica-
tion of the Egr family in this context represents the first report of a link between the two
known signaling pathways involved in positive selection and downstream transcriptional regu-
lators.
 
T
 
he development of immature CD4
 
1
 
8
 
1
 
(double posi-
tive) thymocytes into mature CD4
 
1
 
 or CD8
 
1
 
 (single
positive) T cells is initiated by the TCR-mediated recogni-
tion of MHC molecules expressed by thymic stroma. Al-
though this process, termed positive selection, is accompa-
nied by a number of easily observed changes in expression
of cell surface proteins, most notably the loss of either CD4
or CD8 coreceptor, there is little known about control of
this receptor mediated differentiation event at the level of
gene regulation. Certainly, TCR-generated intracellular sig-
nals must rapidly change the activity and/or expression of
transcriptional regulators which then elicit a cascade of cell
type specific changes in gene expression necessary for es-
tablishment of the mature T cell phenotype. Immediate
early genes, defined as those genes whose expression is not
dependent upon de novo protein synthesis, are likely can-
didates as rapid response mediators between cell surface re-
ceptor generated signals and downstream changes in gene
expression.
Early growth response-1 (
 
Egr-1
 
1
 
;
 
 
 
also known as zif268,
Krox-24, tis-8, NGFI-A, and pAT 225) is one such imme-
diate early gene that was independently isolated from fibro-
blasts activated by serum or phorbol ester (1–5), from PC12
cells that were induced to undergo neuronal differentiation
by nerve growth factor treatment (6), and from mitogen
and phorbol ester activated peripheral blood T lympho-
cytes (7). The Egr-1 protein is a transcriptional regulator
containing three zinc finger structural domains of the Cys
 
2
 
-
His
 
2
 
 type (8), with each zinc finger interacting with two
guanines in a three base pair subsite of a minimum non-
amer binding sequence (9–11). In addition to the DNA
binding domain, both activation and inhibitory regions
have been identified in Egr-1 (12–14), the latter of which
binds a recently identified repressor protein (15). Based upon
conservation of DNA binding domains, Egr-1 belongs to a
family of transcription factors which also include Krox-20/
Egr-2/pAT 591 (16–19), Egr-3 (20), and Egr-4 /NGFI-C/
pAT133 (20–22). Members of the Egr-1 family share 
 
z
 
90%
amino acid identity in the zinc finger domain.
Egr-1 is expressed by diverse cell types in response to
mitogens, differentiation signals, tissue or radiation injury,
or neuronal excitation (23). The widespread expression of
Egr-1 suggests that this transcriptional regulator may play a
role in coupling common biochemical signaling pathways
to rapid changes in gene expression. Although the function
of Egr-1 remains to be elucidated in most systems, expres-
 
1
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sion of Egr-1 in cultured hematopoietic precursor cell lines
has been shown to block granulocytic differentiation al-
though allowing differentiation to the macrophage lineage
(24, 25), demonstrating the potential for this transcription
factor to impact cell lineage commitment. Recently, it has
also been reported that Egr-1 regulates a panel of genes in-
volved in the growth factor and clotting response to endo-
thelial cell injury (26, 27).
In lymphocytes, Egr-1 and other family members are in-
duced in both B and T cells upon antigen receptor cross-
linking or in response to mitogens or phorbol esters (1, 28–
32). Interestingly, in B lymphocytes, inducible expression of
Egr-1 has been correlated with the developmental stage of the
cell. Thus, mature but not immature B cells can be induced
to express Egr-1 upon stimulation with phorbol esters or anti-
IgM antibodies (33). In addition, Fc receptor cross-linking,
which can negatively regulate anti-immunoglobulin medi-
ated B cell activation, inhibits Egr-1 induction (34, 35).
Together, these results suggest a developmentally regulated
positive role for Egr-1 in B cell activation. However, IL-4
can overcome Fc receptor mediated inhibition of B cell
proliferation, without increasing Egr-1 mRNA (34). Thus,
the role of Egr-1 in mature lymphocyte function may de-
pend upon the specific means of cell activation. In the adult
mouse, high levels of Egr-1 mRNA are found in the brain,
thymus, heart muscle, and lung as well as lower levels in
other tissues (2–4, 36, 37). The source of thymic Egr-1 ex-
pression has not been previously investigated.
We have described an in vitro culture system, using the
DPK cell line, that allows us to analyze the TCR mediated
transition of a double positive T cell to a CD4 single posi-
tive T cell (38). Using a PCR based subtractive hybridiza-
tion method, we have identified 
 
Egr-1
 
 as a gene that is rap-
idly induced during the differentiation of DPK cells. Based
upon this finding, we have analyzed the expression of Egr-1
in normal thymus. We report here that high level Egr-1
mRNA, protein and DNA binding activity is associated with
thymic selection, and may represent one of the earliest mark-
ers of TCR engagement in the thymus. We also present
evidence that expression of the Egr family in this cell type
is dependent upon ras and calcineurin signaling pathways,
as is immature T cell differentiation. Our identification of
the Egr family in this context represents an important link
between signaling pathways involved in positive selection
and downstream regulators of gene expression.
 
Materials and Methods
 
Mice.
 
Mice were obtained from the Scripps Research Insti-
tute rodent breeding colony. MHC-deficient mice were pro-
duced by breeding class II MHC knockout mice (39) with 
 
b
 
2
microglobulin knockout mice (40) and were obtained from Dr. J.
Sprent (The Scripps Research Institute).
 
Cells, Assays, and Antigens.
 
The derivation, maintenance and
differentiation of the DPK cell line has been described previously
(38). DPK cell lines expressing H-rasN17, a dominant negative
mutant of p21ras, were generated by retroviral mediated gene trans-
fer as previously described (41) using the pZip-RasH(17N) con-
struct generously provided by Dr. C. Der (University of North
Carolina at Chapel Hill) (42). In brief, DPK cells were infected
by co-culture with a PA317 retroviral packaging cell line that had
been previously transfected with pZip-RasH(17N). After 2 d, DPK
cells were transferred off of the packaging line into complete me-
dium containing G418. The resulting G418 resistant DPK cell lines
were analyzed phenotypically and functionally as described in the
text. DPK cells that expressed RasH(17N) were grown under iden-
tical conditions to wild-type DPK, and no alterations in growth
rate or morphology were noted. DCEK-ICAM is a fibroblast cell
line transfected with class II MHC E
 
k
 
 and ICAM-1 genes (43).
DPK cells were activated by pigeon cytochrome c peptide 88-
104 (synthesized at The Scripps Research Institute) and DCEK-
ICAM cells as described previously (38). In some experiments, DPK
cells or thymocytes were treated with 2C11 anti-CD3
 
e
 
 mAb
(PharMingen, San Diego, CA) pre-adsorbed to plastic tissue cul-
ture dishes (10 
 
m
 
g/ml) or 5-
 
m
 
m polystyrene latex beads (10 
 
m
 
g
2C11 per 10
 
7
 
 beads) (Interfacial Dynamics Corporation, Portland,
OR). For isolation of RNA, 1 
 
3 
 
10
 
7
 
 cells were cultured in a
2C11-coated 100-mm culture dish, or with 2C11-coated beads at
a cell/bead ratio of 1:1.
 
Western Blot.
 
DPK cells were lysed in 1% NP-40 in PBS
containing 2 
 
m
 
g/ml aprotinin (Sigma Chem. Co., St. Louis, MO),
2 
 
m
 
g/ml leupeptin (Sigma) and 1 mM PMSF (Sigma). Cell lysates
were incubated on ice for 15 min and the post-nuclear superna-
tant recovered by microcentrifugation. 20 
 
m
 
g of total protein was
subjected to SDS-PAGE (12%) and transferred to PVDF membrane
(Millipore Corp., Bedford, MA). The membrane was blocked
with 5% nonfat milk in wash buffer (0.15 M NaCl, 10 mM Tris,
pH 7.4, 2.5 mM MgCl
 
2
 
/0.5% Tween 20) and probed with a
monoclonal anti-Ras antibody (Transduction Laboratories, Lex-
ington, KY) diluted in 2.5% nonfat milk in wash buffer. The blot
was extensively washed and developed with the addition of per-
oxidase-conjugated goat anti–mouse IgG antibody (Bio-Rad
Laboratories, Hercules, CA) and visualized using the Enhanced
Chemiluminescence Detection System (Amersham, Arlington
Heights, IL).
 
Antibodies and Staining.
 
Phycoerythrin-conjugated anti-CD4
(GIBCO BRL, Gaithersburg, MD), Red613-conjugated (GIBCO
BRL) or cychrome-conjugated (PharMingen) anti-CD8
 
a
 
, bioti-
nylated anti-CD69 or anti-CD3 (PharMingen) mAbs were used
in FACS
 
Ò
 
 analysis. Cell surface staining was performed as de-
scribed previously (38), and stained cells were analyzed on a
FACScan
 
Ò
 
 or FACSort
 
Ò
 
 using CellQuest software (Becton Dick-
inson, Mountain View, CA). Shown is the log fluorescence of
5,000–20,000 viable cells, gated according to their sideways and
forward light scatter.
For four-color FACS
 
Ò
 
 analysis, thymocytes (3 
 
3
 
 
 
10
 
6
 
) from a
young adult B10.BR mouse were surface stained by standard pro-
cedures with anti-CD4-PE and anti-CD8-cychrome in conjunc-
tion with biotinylated anti-CD69 or anti-CD3 followed by APC-
streptavidin (Biomedia, Foster City, CA). To stain for Egr-1, cells
were washed in staining buffer (PBS, 3%, FCS, 0.1% azide) and
fixed in 200 
 
m
 
l of 3% formaldehyde in PBS for 30 min at 4
 
8
 
C.
Cells were washed in staining buffer, resuspended in 100 
 
m
 
l of
0.5% Triton X-100 in PBS and incubated for 10 min at room
temperature. After a wash in staining buffer, cells were resus-
pended in 100 
 
m
 
l blocking buffer (5% goat serum in 0.1 M Tris,
pH 7.2, 0.01% Triton X-100) and incubated for an additional 10
min. Anti-Egr-1 peptide antiserum (C-19) (Santa Cruz Biotech-
nology, Santa Cruz, CA) was added to cells at a final dilution of
1:1,200 and incubation continued for an additional 30 min at
room temperature. Cells were then washed and incubated with 
733
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FITC-conjugated F(ab
 
9
 
)
 
2
 
 anti-rabbit IgG (Jackson ImmunoResearch
Labs., West Grove, PA) for 30 min at room temperature. After a fi-
nal wash, stained cells were analyzed on a FACSort
 
Ò
 
 upgraded to
a FACSCaliber
 
Ò
 
 with the addition of a second diode laser and
FL4 detector.
For immunohistology, cryostat thin sections (8–10 
 
m
 
) of thy-
mus were fixed in 3% formaldehyde in PBS, incubated with 0.5%
Triton X-100 for 10 min, and blocked for 10 min in 5% goat
serum in 0.1 M Tris, pH7.2, containing 0.01% Triton X-100. Sec-
tions were stained with a specific affinity-purified rabbit anti-Egr-1
peptide antiserum (Santa Cruz Biotechnology) for 1 h followed by
peroxidase-coupled F(ab
 
9
 
)
 
2
 
 donkey anti–rabbit IgG antiserum
(Jackson ImmunoResearch Labs.) for 30 min. For control stain-
ing, the anti-Egr-1 peptide antiserum was preincubated for 2 h
at room temperature with a 10-fold excess by weight of the im-
munizing peptide (Santa Cruz Biotechnology). Staining was de-
veloped with 3,3
 
9
 
-diamino benzidine tetrahydrochloride (Pierce,
Rockford IL) and sections were lightly counterstained in Gill’s
Hematoxylin Solution Number 2 (Sigma) followed by acid alco-
hol and sodium bicarbonate treatments. Sections were dehydrated
in increasing concentrations of alcohol, cleared with Hemo-De
(Fisher, Pittsburgh, PA) and coverslips mounted in DPX mount-
ing media (BDH Laboratory Supplies, Poole, UK).
 
Representational Difference Analysis.
 
TRIzol Reagent (GIBCO
BRL) was used to prepare total RNA from DPK cells 6 h after in-
cubation with FcR
 
1
 
 CHO cells (a gift from Dr. I. Mellman, Yale
University) in the presence or absence of soluble 2C11 anti-
CD3
 
e
 
 mAb. Poly(A)
 
1
 
 RNA was isolated from total RNA using
oligo-dT magnetic beads (Dynal, Lake Success, NY). Double
stranded cDNA was prepared using SuperScript reverse tran-
scriptase (GIBCO BRL) according to the manufacturer’s instruc-
tions and digested with DpnII (New England Biolabs). Rep-
resentational difference analysis was performed as described by
Hubank and Schatz (44). cDNA prepared from DPK cells incu-
bated with FcR
 
1
 
 CHO cells was used as driver, and cDNA pre-
pared from identical cultures but with the addition of anti-CD3
 
e
 
mAb was used as tester. Final products were purified from agarose
gels, cloned into the TA cloning vector (Invitrogen, San Diego,
CA) and sequenced using Taq cycle sequencing (Perkin-Elmer,
Norwalk, CT). Sequence similarity searches identified four frag-
ments of 705, 671, 434, and 280 bp as DpnII fragments of the
murine 
 
Egr-1
 
 gene.
 
RT-PCR.
 
Total RNA was prepared from DPK cells or thy-
mocytes using TRIzol Reagent (GIBCO BRL) or RNeasy RNA
Kit (Qiagen, Chatsworth, CA). Oligo-dT primed first strand
cDNA was prepared from 1-4 
 
m
 
g of total RNA using the Super-
Script Preamplification System (GIBCO BRL) according to the
manufacturer’s instructions. PCR was performed in a total vol-
ume of 25 
 
m
 
l containing 10 pmol of each primer, 1
 
3
 
 PCR buffer
(GIBCO BRL), 0.2 mM dNTPs, 2 mM MgCl
 
2
 
, 1 U Taq poly-
merase (GIBCO BRL), and 1–5 
 
m
 
l appropriately diluted cDNA.
Cycle conditions were: 94
 
8
 
C for 4 min followed by 28–30 cycles
of 94
 
8
 
C for 30 s, 58 or 61
 
8
 
C (for 
 
Egr-3
 
) for 40 s and 72
 
8
 
C for 1
min. After a final incubation at 72
 
8
 
C for 2 min, loading dye was
added and the reactions were run on a 2.0% agarose gel. PCR
products were visualized by ethidium bromide staining.
Competitive RT-PCR was performed as described above
but with the addition of various concentrations of the E4 com-
petitor construct. E4 contains both 
 
Egr-1
 
 and 
 
CD4
 
 primer sites
flanking an irrelevant DNA sequence. Amplification of E4 with
appropriate primers results in PCR products of 395 bp (CD4) and
447 bp (Egr-1), while CD4 and Egr-1 cDNA yields PCR prod-
ucts of 486 bp and 356 bp, respectively. To measure the concen-
tration of specific cDNA in a sample, a constant amount of
cDNA was added to reaction tubes containing known concentra-
tions of E4 competitor. Separate PCR reactions were run with
CD4 and Egr-1 primers. Competitor and cDNA-derived PCR
products were separated by agarose gel electrophoresis and stained
with ethidium bromide. Fluorescence images were captured to
disk using an ImageStore 7500 system (UVP, Inc., Upland, CA)
and band intensities were quantitated using NIH Image software.
The ratio of competitor to cDNA-derived PCR product was cal-
culated and plotted versus E4 concentration. The concentration
of specific cDNA in the sample was taken as the concentration of
E4 to yield a band ratio of 1. A minimum of two independent
competitive PCR assays were run to determine the specific
cDNA concentration of an individual sample.
Upstream and downstream primer sequences used in RT-PCR
were derived from different exons. Primer pairs were as follows:
CD4, 5
 
9
 
-CTGATGTGGAAGGCAGAGAAGGATTC/5
 
9
 
-CAG
CACGCAAGCCAGGAACACTGTCT; Egr-1, 5
 
9
 
-AATCCT-
CAAGGGGAGCCGAGCGAACA/5
 
9
 
-GAGTAGATGGGAC-
TGCTGCTGTCGTTGGA; N-Ras, 5
 
9
 
-GGTGGTGGTTGGAG-
CAGGTGGTGTTG/5
 
9
 
-CCATGGGGACATCATCAGAATC-
TTTC; Egr-2, 5
 
9
 
-CCCCTTTGACCAGATGAACGGAGTGG/
5
 
9
 
-TGGATGGCGGCGATAAGAATGCTGAA; Egr-3, 5
 
9
 
-CGA-
CTCGGTAGCCCATTACAATCAGA/5
 
9
 
-GAGATCGCCGC-
AGTTGGAATAAGGAG; CD69, 5
 
9
 
-CTACCTGCAAGAAT-
GAGTGGATTTCA/5
 
9
 
-TTTTGTGGTTCACGGACACGCA-
CCTC.
 
Electrophoretic Mobility Shift Assay.
 
Oligonucleotides containing
an Egr-1 consensus site (underlined), 5
 
9
 
-CCCGGCGCGGGG-
GCGATTTCGAGTCA and 5
 
9
 
-TGACTCGAAATCGCCC or
overlapping Egr-1/SP1 sites (SP1 site in bold) 5
 
9
 
-GGAGGAGCG-
GCG
 
GGGGCGGGC
 
GCCGG and 5
 
9
 
-CCGGCGCCCGCC-
CCGC, were annealed and labeled in a fill-in reaction using
[
 
a
 
32
 
P]dCTP (ICN, Costa Mesa, CA) and Klenow fragment of
DNA polymerase (GIBCO BRL) as previously described (26).
Labeled oligonucleotide probes were separated from free nucle-
otides using spin columns (Qiagen) and 
 
z
 
3
 
 3 
 
10
 
5
 
 cpm probe
(2–10
 
 3 
 
10
 
5
 
 cpm/ ng) was used in each binding reaction. Nu-
clear extracts from 5
 
 3 
 
10
 
6
 
 cells were obtained by resuspending
cells in 100 
 
m
 
l of Buffer A (10 mM Hepes, pH 7.9, 10 mM
KCl, 300 mM Sucrose, 1.5 mM MgCl
 
2
 
, 0.5 mM DTT, 0.5%
NP-40, 10 
 
m
 
g/ml pepstatin, antipain, chymostatin, aprotinin, and
0.1 
 
m
 
g/ml leupeptin, 0.5 mM PMSF). After a 5-min incubation
at 4
 
8
 
C, nuclei were pelleted at 14,000 rpm for 10 s, washed once
with 100 
 
m
 
l of Buffer A, then resuspended in 50 
 
m
 
l of Buffer B
(20 mM Hepes, pH 7.9, 20% glycerol, 100 mM KCl, 100 mM
NaCl, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT, protease
inhibitors as in buffer A). The nuclear extracts were frozen in liq-
uid nitrogen, thawed on ice, sonicated, and stored in aliquots at
 
2
 
70
 
8
 
C. For the gel shift assay, 4–5 
 
m
 
l of nuclear extract was in-
cubated with a radiolabeled DNA fragment for 20 min at room
temperature in a 20 
 
m
 
l reaction containing 1
 
3
 
 binding buffer (20
mM Hepes, pH 7.9, 50 mM KCl, 5.0% glycerol, 1 mM DTT, 1
mg/ml BSA, 0.1% Nonidet P-40, and 50 
 
m
 
g/ml poly dI-dC).
Protein-DNA complexes were separated from unhybridized
probe on 6% non-denaturing acrylamide gels (Novex, San Diego,
CA) in 0.53 Tris borate-EDTA buffer.
Results
Induction of the Egr-1 Transcription Factor in the DPK Thy-
mocyte Cell Line. The DPK cell line was derived from a734 Induction of Egr-1 During Thymic Selection
CD4181 thymic lymphoma of an AND TCR transgenic
mouse (38, 45). This cell line possess the phenotype of im-
mature thymocytes, including expression of RAG-1,2 and
TdT (41), and can be triggered to differentiate into CD4182
cells upon activation by a pigeon cytochrome c peptide and
Ek bearing antigen-presenting cells, or alternatively, by Ek
bearing thymic epithelial cells in vivo or in vitro in the ab-
sence of antigen (38, 46). Although anti-CD3 mAb alone is
a relatively poor inducer of DPK cell differentiation, it is
active at high concentration or in conjunction with acces-
sory molecule stimulation (41, 47). To identify genes in-
volved in the early phase of TCR mediated double positive
thymocyte differentiation, we used representational differ-
ence analysis to compare mRNA derived from DPK cells
that were cultured in the presence or absence of anti-CD3e
mAb (see Materials and Methods). This approach allowed
us to identify the Egr-1 immediate early gene, encoding a
zinc finger transcription factor, as one such candidate gene.
Subsequent RT-PCR analysis confirmed that DPK cells
express little Egr-1 mRNA before activation, but express
high levels as early as 1 h after anti-CD3e mAb stimulation
(Fig. 1 A). Levels of Egr-1 mRNA remain high for at least
5 h but decline by approximately fivefold 1 d after initial
stimulation (Fig. 1 A). To ascertain whether the induction
of Egr-1 mRNA resulted in DNA binding activity, we
performed an electrophoretic mobility shift assay using nu-
clear extracts derived from DPK cells activated by anti-
CD3e mAb. Nuclear extracts from DPK cells in the ab-
sence of activation had no detectable complexes binding to
an oligonucleotide probe containing an Egr-1 consensus
binding sequence (Fig. 1 B), consistent with the low level
of Egr-1 mRNA. In contrast, a single binding complex was
observed in activated DPK cells (Fig. 1 B). This complex
has an identical mobility to that obtained using recombi-
nant Egr-1, and supershifts with an anti-Egr-1 antibody
(not shown). The inducibility of Egr-1 DNA binding ac-
tivity is in contrast to Sp1 DNA binding activity which is
constitutively expressed in DPK cells and is not affected by
stimulation (Fig. 1 B).
Rapid and high level expression of Egr-1 mRNA is also
observed upon activation of DPK cells by pigeon cyto-
chrome c peptide and transfected fibroblast antigen-pre-
senting cells (Fig. 1 C), a potent inducer of DPK cell differ-
entiation (38). In this instance, a competitive PCR assay
was used to quantify and compare levels of Egr-1 and CD4
mRNA. CD4 gene expression was used for comparison be-
cause expression of this gene is maintained throughout
DPK cell differentiation (38). DPK cells activated by anti-
gen and antigen-presenting cells or anti-CD3e mAb ex-
press 20–30-fold higher levels of Egr-1 than CD4 mRNA
(Fig. 1 C).
Egr-1 is one of a family of transcription factors that share
a highly conserved DNA binding domain consisting of
three zinc finger motifs. To determine whether gene ex-
pression of other family members was also upregulated
upon activation of immature T cells, we examined gene
expression of Krox-20, the murine homologue of human
Egr-2 (16, 18), and Egr-3 (20) in DPK cells. Neither Krox-
20 (Egr-2) nor Egr-3 mRNA was detected by RT-PCR in
unactivated DPK cells, while both genes were induced af-
ter anti-CD3e mAb stimulation (Fig. 2 C). Both Krox-20
(Egr-2) and Egr-3 RT-PCR products were sequenced to
confirm identity of the expressed genes.
Cyclosporin A Inhibits DPK Differentiation and Egr-2,3, but
not Egr-1 Gene Expression. Our results have demonstrated
Figure 1. The Egr-1 gene is rapidly induced after TCR-mediated acti-
vation of the DPK double positive cell line. (A) Total RNA isolated from
DPK cells cultured with immobilized anti-CD3e mAb for the indicated
times (shown in hours), was subjected to RT-PCR analysis using Egr-1
or CD4 primers. (B) Electrophoretic mobility shift assay using nuclear ly-
sates prepared from DPK cells 8 h after activation by immobilized anti-
CD3e mAb. Probes contained a single Egr-1 binding site (left) or overlap-
ping Egr-1 and Sp1 sites (right). (C) DPK cells were cultured with
DCEK-ICAM fibroblast antigen presenting cells and 1 mm pigeon cyto-
chrome c peptide for the indicated times. Total RNA was isolated and
subjected to a competitive RT-PCR assay (see Materials and Methods).
Note the different scales for Egr-1 and CD4 mRNA expression.735 Shao et al.
that TCR engagement in the immature double positive DPK
cell line leads to upregulation of members of the Egr gene
family. However, it remained to be determined whether
induction of these genes was downstream of signaling path-
ways that were required for immature T cell differentiation.
Cyclosporin A (CsA), a potent inhibitor of calcineurin, has
been reported to block positive selection (36, 48, 49). To
investigate whether Egr gene expression in double positive
cells was also dependent upon calcineurin activation, we
tested the ability of CsA to block Egr induction in DPK
cells. As observed for the production of single positive thy-
mocytes, CsA inhibits the production of CD4 single posi-
tive DPK cells upon activation by antigen and antigen pre-
senting cells (Fig. 2 B). Downregulation of cell surface CD8
as early as 24 h after activation was also blocked by CsA
Figure 2. DPK cell differentiation and Egr-2,3 mRNA induction is
cyclosporin A sensitive, while Egr-1 mRNA induction is cyclosporin A
resistant. (A, B) DPK cells were cultured with DCEK-ICAM fibroblast
antigen presenting cells and 2 mM pigeon cytochrome c peptide in the
presence or absence of 100 ng/ml cyclosporin A, or appropriate dilution
of solvent (DMSO) as indicated. Cells were harvested and stained for
CD69 after 1 or 3 d in culture (A) or stained for CD4 and CD8 after 3 d
in culture (B). (C) RT-PCR analysis of total RNA derived from DPK
cells activated for 6 h with immobilized anti-CD3e mAb in the presence
or absence of 300 ng/ml cyclosporin A, using Egr-1, Egr-2 (Krox-20),
CD4, CD69 or Egr-3 primers. (*) Also shown for the indicated samples is
the relative level of Egr-1 cDNA normalized to expression of CD4 cDNA
as determined by competitive RT-PCR assay. The identity of the lower
major band in Egr-3 RT-PCR was verified by sequencing.
Figure 3. Expression of a dominant negative mutant of p21ras blocks
DPK cell differentiation. (A) RT-PCR assay of N-ras expression in DPK
cells or thymocytes derived from wild-type or MHC-deficient mice. (B)
Cell lysates from DPK cells and four independent lines that express Ha-ras
N17 were analyzed by Western blot and probed with anti-ras antibody.
Endogenous p21ras is not visible in this exposure. (C) DPK or 17N4 cells
were cultured with DCEK-ICAM fibroblast antigen presenting cells in the
presence (bold lines) or absence (thin lines) of 2 mM pigeon cytochrome c
peptide. After 3 d of culture, cells were collected, stained with mAb to
CD69 and analyzed by flow cytometry. (D) DPK or 17N4 cells were cul-
tured as in (C) except that cells were harvested on day 1 or 3 as indicated
and stained with anti-CD4 and anti-CD8 mAbs. Shown are the percent-
ages of CD418lo/- DPK cells in the designated regions.736 Induction of Egr-1 During Thymic Selection
(not shown), indicating that calcineurin was involved in
the initiation of this process and not simply single positive
cell survival.
One of the earliest cell surface markers of positive selec-
tion in the thymus (50–52) and in DPK cells (38) is CD69.
No significant effect of CsA on the early induction of
CD69 mRNA was observed in activated DPK cells (Fig. 2 C).
At 24 h after activation, CsA partially reduced but did not
eliminate CD69 cell surface expression on DPK cells (Fig.
2 A). By 3 d, however, CD69 surface expression was ab-
sent from DPK cells, suggesting that calcineurin may be in-
volved in maintenance but not induction of CD69 expres-
sion. In summary, although early CD69 gene induction is
relatively resistant to the effects of CsA, the initiation of
differentiation to a single positive cell is clearly CsA sensi-
tive. CsA, however, had little effect on the induction of
Egr-1 mRNA. Using expression of CD4 for normalization,
DPK cells that were activated in the presence of CsA ex-
pressed z70% of the levels of Egr-1 mRNA expressed by
cells activated in the absence of CsA (Fig. 2 C). In contrast,
CsA almost completely blocks induction of Egr-2 (Krox-
20) and Egr-3 mRNA (Fig. 2 C). Thus, activation of some,
but not all members of the Egr gene family are downstream
of a signaling pathway required for positive selection.
Both DPK Differentiation and Egr Gene Expression are Blocked
by a Dominant Negative Mutant of p21Ras. It has been dem-
onstrated that there is an inhibition of the production of sin-
gle positive thymocytes in transgenic mice that express dom-
inant negative mutants of p21ras or MEK (53, 54). Thus,
we sought to determine the effect of a block in ras signaling
upon expression of the Egr family in double positive cells.
In addition, because positive selection may be a multi-step
process, it was not clear from transgenic experiments whether
ras activation was required for the initiation of the double
positive to single positive transition or, alternatively, for
thymocyte survival or other later events.
As shown in Fig. 3 A, N-ras mRNA can be detected in
normal thymocytes, thymocytes derived from MHC-defi-
cient mice (.90% double positive, Fig. 2 A), and DPK
cells. This is consistent with previous reports of expression
of both N-ras and K-ras in double positive thymocytes
(53). To study the role of p21ras in Egr gene expression in
immature T cells, retroviral mediated gene transfer was
used to express a dominant negative mutant of p21ras, Ha-
ras N17 (with an asparagine substituted for serine at posi-
tion 17) in DPK cells. This mutant blocks endogenous ras
function by competing for guanine nucleotide exchange
proteins, thereby preventing formation of ras-GTP com-
plexes (42). Fig. 3 B shows expression of Ha-ras N17 in
four independent DPK cell transformants that express high
levels of this dominant negative mutant. The results ob-
tained with line 17N4 are described here, although all four
cell lines had similar responses.
One major difference between DPK cells and the major-
ity double positive thymocyte population is that DPK cells are
rapidly dividing. Given the potential role of ras as a proto-
oncogene it was possible that a block in p21ras-mediated
signaling would alter DPK cell growth and secondarily dif-
ferentiation. However, the overexpression of rasN17 had no
effect on the growth of DPK cells, nor were any changes in
morphology observed (not shown). In addition, both DPK
and 17N4 cells displayed similar abilities to mobilize cal-
cium after TCR engagement (not shown). In Jurkat cells,
activation of p21ras is both necessary and sufficient for in-
duction of the early activation marker CD69 (55). Simi-
larly, expression of rasN17 in DPK cells abrogates surface
expression of CD69 upon activation (Fig. 3 C). In addi-
tion, RT-PCR analysis demonstrated that CD69 mRNA
could be detected as early as 6 h after activation by antigen
in wild-type but not 17N4 cells (not shown). This is in
contrast to the effects of CsA, which had little effect on
early CD69 induction. In response to antigen, DPK cells
transit from a double positive to a CD4182 single positive
phenotype. Similar to normal thymocytes, the loss of cell
surface CD8 in DPK cells is a gradual process, and transi-
tional cells with low levels of CD8 are observed at early
time points (Fig. 3 D). The production of CD4 single pos-
itive cells in response to antigen is almost completely inhib-
ited in 17N4 cells, even at these early time points (Fig. 3 D).
Figure 4. Expression of Egr gene family is dependent upon ras signaling
pathways. (A) Competitive RT-PCR was used to compare expression of
Egr-1 and CD4 genes in DPK or 17N4 cells activated for 6 h with immo-
bilized anti-CD3e mAb. (B) RT-PCR analysis of total RNA derived
from DPK or 17N4 cells activated for 6 h with immobilized anti-CD3e
mAb. Independent PCR reactions using Egr-2 (Krox-20), CD4, or Egr-3
primers were performed.737 Shao et al.
Together, these results indicate that p21ras signaling is re-
quired for initiation of DPK cell differentiation to a CD4
single positive cell.
Having determined that DPK cell differentiation was de-
pendent upon ras activation, we sought to determine
whether the expression of the Egr gene family was also
downstream of this signaling pathway. As shown in Fig.
4 A, induction of Egr-1 mRNA in DPK cells was blocked
by expression of the dominant negative mutant of p21ras.
Similarly, there was no detectable induction of Egr-2
(Krox-20) or Egr-3 mRNA in these cells after stimulation
by anti-CD3e mAb (Fig. 4 B). This is in contrast to CsA,
which differentially affects the expression of the Egr family.
Egr-1 Is Expressed by Double Positive Thymocytes In Vivo as
a Result of Recognition of MHC. The neonatal and adult
rat thymus has been reported to express Egr-1 mRNA (37).
Our results in the DPK system suggested that Egr-1 expres-
sion in normal thymus might be the result of positive selec-
tion. To address this issue, we used competitive RT-PCR
to analyze Egr-1 gene expression in normal thymocytes and
in thymocytes derived from double gene knockout mice
that do not express class I or class II MHC molecules (39,
40). These latter animals have normal numbers of double
positive thymocytes but lack single positive thymocytes
due to the inability of TCR bearing immature thymocytes
to undergo positive selection (Fig. 5 A). Freshly isolated
thymocytes from MHC-deficient animals expressed approxi-
mately 10–20-fold less Egr-1 mRNA than normal thymo-
cytes (Fig. 5 B). In contrast, expression of the CD4 gene
was similar in both groups of animals, consistent with the
expression of this coreceptor by .90% of thymocytes in
both normal and MHC-deficient mice (Fig. 5 A). To ana-
lyze functional Egr-1 protein expression, gel mobility shift
assays were performed using nuclear extracts derived from
freshly isolated thymocytes. Consistent with the pattern of
Egr-1 mRNA expression, Egr-1 DNA binding activity was
detected in nuclear lysates of thymocytes derived from
wild-type but not MHC-deficient animals (Fig. 5 C). This
complex has an identical mobility to that obtained with re-
combinant Egr-1 and supershifts with an anti–Egr-1 anti-
body (Fig. 5 C).
These results suggested that activation of the Egr-1 gene
occurred during MHC-dependent selection of double pos-
itive thymocytes. However, the data were also consistent
with the possibility that Egr-1 was upregulated only in ma-
ture single positive thymocytes, subsequent to positive se-
lection. To distinguish these possibilities we analyzed the
expression of Egr-1 in purified double positive thymocytes
derived from normal mice. Given the rapid induction of
Egr-1 mRNA in DPK cells (Fig. 1) one would predict that
if Egr-1 was induced during thymic selection, it would be
expressed before loss of the double positive phenotype.
This was found to be the case, and a significant amount of
Egr-1 mRNA was detected in double positive thymocytes
isolated by cell sorting (Fig. 6 A). Isolated double positive
thymocytes also expressed Egr-1 DNA binding activity, as
did CD4 single positive thymocytes (not shown). To dem-
onstrate that the Egr-1 gene could be induced by TCR ac-
tivation in double positive thymocytes, thymocytes derived
from MHC-deficient mice were stimulated with immobi-
lized anti-CD3e mAb. As shown in Fig. 6 B, TCR activa-
tion results in rapid upregulation of Egr-1 mRNA in these
cells. In contrast, Egr-1 is not upregulated in thymocytes
derived from MHC-deficient mice upon treatment in cul-
ture with doses of dexamethasone or ionizing radiation that
induce cell death (not shown).
Figure 5. Egr-1 mRNA and DNA binding activity in the thymus is
MHC dependent. (A) Thymocytes derived from wild-type or MHC-
deficient mice were two color-stained for CD4 and CD8. (B) Competi-
tive RT-PCR was used to determine the level of expression of CD4 and
Egr-1 genes in thymocytes derived from wild-type or MHC-deficient
mice. (C) Electrophoretic mobility shift assay using nuclear lysates pre-
pared from freshly isolated thymocytes derived from wild-type or MHC-
deficient mice using a probe containing an Egr-1 binding site. Nuclear
extracts derived from 5 3 105 cells containing equivalent amounts of pro-
tein were used in binding reactions. In some instances as indicated, bind-
ing reactions contained anti-Egr-1 antibody or normal rabbit serum
(NRS). For comparison, a binding reaction containing recombinant Egr-1
is shown.738 Induction of Egr-1 During Thymic Selection
Similar to results obtained with DPK cells, both Krox-20
(Egr-2) and Egr-3 mRNA are also expressed in normal thy-
mocytes, while there is no detectable expression of these
genes in thymocytes derived from MHC-deficient animals
(Fig. 7). These results are consistent with the coordinate
upregulation of the Egr family of transcription factors dur-
ing thymic selection.
To determine the location of cells within the thymus
that express Egr-1 protein, thin sections of normal thymus
were stained with a specific anti–Egr-1 peptide antiserum
(Fig. 8). Isolated cells scattered throughout the cortex were
found to express Egr-1. No enrichment of Egr-1 express-
ing cells in the subcapsular region or cortico-medullary
junction was observed. These results are consistent with in-
duction of Egr-1 in cortical double positive thymocytes as a
result of TCR engagement. Most, but not all, medullary
cells also stained, indicating that Egr-1 protein is expressed
in a substantial number of single positive thymocytes as
well (see below). In contrast, few cells stained in the thymic
cortex of MHC-deficient mice, and in general the staining
was weak, even in medullary regions (Fig. 8).
The expression of Egr-1 in thymocyte subsets was fur-
ther analyzed by FACSÒ using three-color surface staining
in conjunction with a fourth color for internal staining
(Fig. 9). Using this method, a subset of thymocytes could
be detected that stained with the anti–Egr-1 antiserum.
This subpopulation included the majority of single positive
thymocytes and ,10% of double positive thymocytes. These
results are consistent with the finding that isolated cortical
thymocytes and most medullary thymocytes stained with
this anti–Egr-1 antiserum. Interestingly, almost all the CD691
or CD3hi thymocytes also stained for Egr-1, while z10%
of thymocytes stained for Egr-1 but were CD3lo or CD692
(Fig. 9). Among double positive thymocytes, .90% of the
cells that stained for Egr-1 were also CD3lo or CD692. A
majority of double negative thymocytes also stained for
Egr-1, although the specificity of this staining remains to be
confirmed by other means.
Discussion
Using representational difference analysis and the DPK
culture system we sought to identify genes that play a role
in the earliest stages of double positive thymocyte differen-
tiation. Egr-1, an immediate early gene encoding a zinc fin-
ger transcription factor, was identified as one such candi-
date. We have demonstrated that the Egr-1 gene is rapidly
induced after TCR mediated stimulation of the double
positive DPK cell line or double positive thymocytes. In
normal mice, Egr-1 mRNA, protein, and DNA binding
activity is expressed by freshly isolated thymocytes, includ-
ing the double positive subset. In contrast, thymocytes de-
rived from MHC-deficient mice, which express a normal
pattern of development through the double positive stage
but which do not undergo positive or negative selection,
express z10–20-fold lower levels of Egr-1 mRNA than
wild-type mice. This correlates with the loss of detectable
Egr-1 DNA binding activity and low level anti–Egr-1 anti-
body staining in thymocytes derived from MHC-deficient
Figure 6. Expression of Egr-1 mRNA in double positive thymocytes.
(A) Total thymocytes and CD4181 thymocytes (isolated by cell sorting,
95% DP) derived from the same animal, were assayed for expression of
Egr and CD4 mRNA by competitive RT-PCR. Shown is the relative
level of Egr-1 cDNA in the sample, normalized to the level of CD4
cDNA. (B) Total thymocytes derived from an MHC-deficient mouse
were cultured with hamster immunoglobulin-coated or anti-CD3e mAb-
coated beads for 90 min before determination of Egr-1 and CD4 gene ex-
pression as in Fig. 1 C.
Figure 7. Expression of Egr-2
and Egr-3 mRNA in thymocytes
is MHC dependent. Total RNA
prepared from freshly isolated
wild-type or MHC knockout
thymocytes was subjected to
RT-PCR analysis using CD4,
Egr-2 (Krox-20), or Egr-3 prim-
ers as indicated.739 Shao et al.
mice. Furthermore, Egr-1 expression is also low in thymo-
cytes derived from TCR a chain knockout mice (not shown),
demonstrating that a TCR–MHC interaction and not, for
example, a coreceptor-MHC interaction, is required for high
level Egr-1 expression in the thymus. These results are in
contrast to expression of Sp1 DNA binding activity which
is constitutively expressed in double positive thymocytes
(56) and DPK cells before and after activation (Fig. 1).
The question then arises as to whether thymocytes that
express Egr-1 are undergoing positive selection. Positive se-
lection of double positive thymocytes is initiated by an in-
teraction with MHC bearing epithelial cells that reside in the
thymic cortex (57). If induction of Egr-1 in double positive
cells is a consequence of positive selection, it would also be
expected to take place in the cortex. This was found to be
the case, and staining of thymic sections for Egr-1 revealed
scattered thymocytes throughout the cortex that expressed
the protein. Egr-1 is also expressed by many medullary (Fig. 8)
and single positive thymocytes (Fig. 9). Whether Egr-1 ex-
pression is maintained or reinduced on these more mature
thymocytes is uncertain, but Egr-1 upregulation has been
associated with both early activation and late differentiation
in other systems (28).
Whereas we can not directly determine the fate of Egr-1
expressing cells in the cortex, thymocytes that have upreg-
ulated CD3 or CD69, including CD418lo transitional thy-
mocytes, also have upregulated Egr-1 (Fig. 9). This pattern
of expression, coupled with our results in the DPK system,
strongly suggests that Egr-1 is induced during positive
selection. Approximately 10% of total thymocytes, the ma-
jority of which are also double positive thymocytes, also
stained for Egr-1 by FACSÒ but were CD3lo or CD692
(Fig. 9). This may reflect the rapid induction of Egr-1 dur-
ing selection, before upregulation of TCR or CD69. The
observed rapid upregulation of Egr-1 in DPK cells and thy-
mocytes as a result of TCR engagement is certainly con-
sistent with this possibility. In the CD4 lineage, in fact,
TCR upregulation occurs subsequent to the double posi-
tive stage and is coincident with downregulation of the
CD8 coreceptor (58). Egr-1 expression may thus represent
one of the earliest markers of positive selection in the thy-
mus. Alternatively, some thymocytes that express Egr-1 at
the double positive stage may fail to progress in their differ-
entiation program or be in the process of negative selection
(see below).
Although Egr-1 expression is associated with thymocyte
Figure 8. Expression of Egr-1 protein in the thymus. Thin sections of normal thymus (A–C) or MHC knockout thymus (D) were fixed in formalde-
hyde and stained with a specific rabbit anti-Egr-1 peptide antiserum (A, C, D) or the same antibody preincubated with specific peptide (B). Regions of
cortex (C) and medulla (M) are indicated. Sections were counterstained with hematoxylin and photographed at 320 (A, B) or 340 (C, D). C shows a
magnification of the same section photographed in A.740 Induction of Egr-1 During Thymic Selection
differentiation, could upregulation of this transcription fac-
tor also occur during negative selection? In support of this,
we have shown that double positive thymocytes stimulated
with anti-CD3 antibody upregulate Egr-1 mRNA. The
signals provided by CD3 cross-linking do not induce posi-
tive selection of isolated normal thymocytes, but can elicit
cell death in conjunction with accessory signals (59). Ex-
pression of Egr-1, therefore, may not be limited to positive
selection but may also be induced during negative selec-
tion. If indeed high level Egr-1 expression results from
both positive and negative selection, the expression pattern
of this transcription factor in the cortex may reveal the ex-
tent of specific TCR engagement in the normal thymus.
Although Egr-1 could be induced during negative selec-
tion, evidence suggests that induction of this transcription
factor is not associated with thymocyte cell death per se.
Although apoptotic thymocytes can be detected in the cor-
tex of normal mice, there is no reduction in the frequency
of such cells in MHC double knockout mice (60). Presum-
ably, cell death in the latter instance is the result of death
by neglect and not negative selection. In contrast, there is
a dramatic reduction in Egr mRNA, protein and DNA
binding activity in MHC knockout mice, suggesting that
thymocyte death by neglect is not associated with Egr-1 up-
regulation. We also failed to detect induction of Egr-1
mRNA in MHC knockout thymocytes subjected to ioniz-
ing radiation or corticosteroids at doses that induce cell death.
This further demonstrates that high level Egr-1 mRNA ex-
pression in the thymus is specifically associated with TCR
activation.
It is unlikely that TCR-mediated selection events are
the only source of Egr-1 gene expression in the thymus,
because some Egr-1 mRNA can be detected in MHC-
deficient animals. Double positive thymocytes may consti-
tutively express the gene at very low levels, because Egr-1
mRNA can also be detected in DPK cells by RT-PCR if
sufficient amounts of cDNA are used. Because the DNA
binding activity of Egr-1 can be influenced by phosphory-
lation (61), both transcriptional and posttranslational mech-
anisms may contribute to the upregulation of functional
Egr-1 in immature thymocytes. In addition, we have ob-
served staining of double negative thymocytes using anti-
Egr-1 antiserum and FACSÒ analysis (Fig. 9). Because dou-
ble negative cells tend to have higher background staining
for many antibodies, this result needs to be confirmed. How-
ever, one intriguing possibility is that Egr-1 is also induced
by pre-TCR activation (62) and plays a role in the differen-
tiative and/or proliferative events that are involved in the
double negative to double positive thymocyte transition.
Egr-1 belongs to a family of transcriptional regulators
Figure 9. Expression of Egr-1 protein in thy-
mocyte subsets. Thymocytes from a young adult
mouse were 4-color stained for expression of CD4,
CD8, Egr-1, and CD69 or CD3, and analyzed by
FACSÒ as described in Materials and Methods. In-
dicated in the dot plots are the percentage of thy-
mocytes within each quadrant, or in parenthesis
(upper right dot plot), the percentage of Egr-11 thy-
mocytes within each thymocyte subset. Where in-
dicated, staining is shown for gated populations of
thymocytes (either Egr-11thymocytes as shown in
histogram, or CD4181 thymocytes). Similar results
were obtained from three other individual animals.741 Shao et al.
that contain closely related DNA binding domains that rec-
ognize similar sequence motifs. However, despite highly
similar DNA binding domains, differences have been found
in the ability of Egr family members to interact with a
given promoter region (63). Thus, the degree of functional
overlap between family members remains an open ques-
tion. Egr-1, 2, 3, and 4 have all been reported to be upreg-
ulated upon activation of human T lymphocytes (19, 64).
We have found that Egr-1, 2, and 3 are also coordinately
upregulated in the thymus, and expression of mRNA for
all three family members is dependent upon expression of
MHC. Somewhat surprisingly given these results, only a
single binding complex is detected in gel shift assays using
thymocyte or DPK nuclear lysates. This complex runs iden-
tically to that obtained with recombinant Egr-1, and the
complex supershifts with an anti–Egr-1 antibody. It is pos-
sible that the failure to detect Egr-2 and Egr-3 containing
complexes is due to lower levels of expression of these tran-
scription factors (19) or to the particular binding conditions
of the assay.
Positive and negative selection are complex processes in-
volving cell activation, cell differentiation and cell survival.
How Egr expression specifically impacts these events is not
known. Egr-1 knockout mice have no gross lymphocyte
abnormality, including the production of mature T cells
(65), while Egr-2 knockouts die as neonates due to hind-
brain abnormalities (66). Whether there are more subtle
changes in T cell development or T cell function in Egr-1
knockout mice, or compensatory effects of other family
members remains to be determined. The critical gene tar-
gets for regulation by Egr family members in the context of
T cell activation or thymocyte development are also un-
known, although Egr-1 has been implicated in regulation
of the IL-2 (63), tumor necrosis factor (67), ICAM-1 (68),
and CD44 (69) genes. The CD69 gene promoter may also
have an Egr-1 binding site (70). Egr-1 has also been re-
ported to regulate delayed early expression of another im-
mediate early gene, nur77 (71), which itself has been impli-
cated in thymocyte cell death (72).
Despite the paucity of target genes known to be regu-
lated by Egr-1, there is a general theme that has emerged as
to its mode of action. Sp1, which shares homology with
Egr-1 in the zinc finger domain, binds a GC-rich but dis-
tinct sequence from that of Egr-1. Egr-1 and Sp1 sites often
overlap in gene promoters, allowing for competition. It has
recently been shown that induction of Egr-1 as a result of
endothelial cell injury can result in displacement of consti-
tutively expressed Sp1, leading to activation of genes in-
volved in wound repair or cell growth (27). A similar dis-
placement of Sp1 by Egr-1 may also play a role in IL-2
gene activation (63) as well as regulation of the Egr-1 gene
itself (73). As shown here, because Sp1 is constitutively ex-
pressed in double positive thymocytes, whereas Egr-1 is
inducible, a similar process may occur in the thymus.
Whether the result of displacement of Sp1 by Egr-1 in the
context of T cell development would result in gene activa-
tion or repression, and how this would impact T cell devel-
opment, must await identification of specific gene targets
for Egr-1 in the thymus.
If indeed there is an induction of Egr family members
during negative as well as positive selection, this does not
imply that these transcription factors play identical roles in
these distinct selection events. To address this issue, we
have asked how signaling pathways impact both double
positive cell differentiation and Egr family expression. Ex-
pression of dominant negative ras or MEK in transgenic
animals has previously been shown to inhibit the appear-
ance of single positive thymocytes (53, 54). Using the DPK
system we have shown here that dominant negative ras also
inhibits the initiation of the double positive to single posi-
tive transition of these cells. This correlates with an inhibi-
tion of the induction of Egr-1,2, and 3. Induction of Egr-1
in B cells has also been shown to be ras dependent (74).
The fact that negative selection (53), and cell death of DPK
cells (Shao, H. and J. Kaye, unpublished observation), is not
impaired under conditions that disrupt ras signaling and Egr
expression suggests that the Egr family is unlikely to play an
obligatory role in negative selection.
We have also examined the effect of the calcineurin in-
hibitor CsA in this system. CsA has previously been shown
to inhibit the production of single positive thymocytes in
vivo (36, 48) and in vitro (49). CsA also blocks the double
positive to single positive transition of DPK cells. In con-
trast to the effects of dominant negative ras, however, there
was minimal effect of CsA on early induction of CD69. In-
duction of Egr-1 was found to be CsA resistant while ex-
pression of Egr-2 and Egr-3 were sensitive to CsA. Induc-
tion of Egr-1 in mature human T lymphocytes has also
been reported to be CsA resistant (75), while induction of
Egr-3 was found to be CsA sensitive (64). Similarly, induc-
tion of Egr-2 but not Egr-1 in a murine B cell line is inhib-
ited by CsA (35). That expression of Egr-2 and 3 requires
both ras and calcineurin signaling pathways is reminiscent
of a similar dual requirement for IL-2 gene activation (76,
77), and the coordinate activity of these signaling pathways
may be a common feature of many aspects of both mature
T cell activation and immature thymocyte differentiation.
There have been conflicting reports of whether CsA also
blocks negative selection (36, 48, 49, 78), although the fact
that CsA blocks positive selection is certainly a complicat-
ing factor. Nevertheless, it is clear that the Egr transcription
factor family is specifically induced by TCR activation in
immature thymocytes and lies downstream of the two
known pathways that are required for positive selection.
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